Methylation-mediated miR-155-FAM133A axis contributes to the attenuated invasion and migration of IDH mutant gliomas.

Gliomas with isocitrate dehydrogenases gene mutations (IDH) were found to be less aggressive than their wildtype (IDH) counterparts. However, the mechanism remains unclear. The current study aims to investigate the role of silenced oncogenic microRNAs in IDH gliomas, which were largely ignored and may contribute to the less aggressive behavior of IDH gliomas. Microarrays, bioinformatics analysis of the data from TCGA and qPCR analysis of samples from our experimental cohort (LGG: IDH = 10, IDH = 31; GBM: IDH = 34, IDH = 9) were performed. The results show that miR-155 was consistently down-regulated in IDH gliomas. Establishment of IDH1 overexpressing glioma cell line and bisulfite sequencing PCR suggested that miR-155 down-regulation was associated with IDH1 mutation induced promoter CpG islands methylation. The cancer testis antigen FAM133A is a direct downstream target of miR-155 and is a negative regulator of glioma invasion and migration possibly by regulating matrix metallopeptidase 14 (MMP14). Together, we found that methylation-regulated miR-155-FAM133A axis may contribute to the attenuated invasion and migration of IDH gliomas by targeting MMP14.